Published in J Clin Epidemiol on May 01, 1997
The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol (2000) 3.43
Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. Br J Clin Pharmacol (1998) 1.40
Multi-dose drug dispensing and inappropriate drug use: A nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care (2008) 1.30
Patient medication adherence: measures in daily practice. Oman Med J (2011) 1.29
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI. Atherosclerosis (2011) 1.27
Drug use of children in the community assessed through pharmacy dispensing data. Br J Clin Pharmacol (2000) 1.27
The use of nationwide on-line prescription records improves the drug history in hospitalized patients. Br J Clin Pharmacol (2007) 1.18
Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol (2005) 1.10
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older population. BMC Health Serv Res (2013) 1.01
Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med Care (2006) 1.00
Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol (2002) 0.96
Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated? Br J Clin Pharmacol (2002) 0.95
Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer. Br J Cancer (2011) 0.93
Correspondence between general practitioner-reported medication use and timing of prescription dispensation. Clin Epidemiol (2012) 0.93
Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos (2009) 0.90
Effectiveness of nebulizer use-targeted asthma education on underserved children with asthma. Arch Pediatr Adolesc Med (2006) 0.90
Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study. J Hypertens (2008) 0.89
Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients. BMC Cardiovasc Disord (2011) 0.88
Validation of the Provincial Transfer Authorization Centre database: a comprehensive database containing records of all inter-facility patient transfers in the province of Ontario. BMC Health Serv Res (2006) 0.87
Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data. Pharmacoepidemiol Drug Saf (2010) 0.87
A pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), India. J Young Pharm (2010) 0.86
Long-term persistence with anti-osteoporosis drugs after fracture. Osteoporos Int (2015) 0.85
A method for calculating adherence to polypharmacy from dispensing data records. Int J Clin Pharm (2013) 0.85
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain. PLoS One (2012) 0.84
The use of over-the-counter drugs among surgical and medical patients. Eur J Clin Pharmacol (2004) 0.84
Concurrent acute illness and comorbid conditions poorly predict antibiotic use in upper respiratory tract infections: a cross-sectional analysis. BMC Infect Dis (2007) 0.84
Estimating the information gap between emergency department records of community medication compared to on-line access to the community-based pharmacy records. J Am Med Inform Assoc (2013) 0.84
Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1,300,000 older people. Eur J Clin Pharmacol (2011) 0.84
Influence of retirement on nonadherence to medication for hypertension and diabetes. CMAJ (2013) 0.82
Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent. Circ Cardiovasc Qual Outcomes (2011) 0.82
Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clin Epidemiol (2016) 0.82
Prescribed doses of inhaled steroids in Dutch children: too little or too much, for too short a time. Br J Clin Pharmacol (2006) 0.81
An algorithm to identify medication nonpersistence using electronic pharmacy databases. J Am Med Inform Assoc (2015) 0.80
Gout after living kidney donation: correlations with demographic traits and renal complications. Am J Nephrol (2015) 0.80
Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register study. PLoS One (2013) 0.80
Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions. Br J Clin Pharmacol (2010) 0.80
The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study. Eur J Clin Pharmacol (2008) 0.79
Metabolic profiling and population screening of analgesic usage in nuclear magnetic resonance spectroscopy-based large-scale epidemiologic studies. Anal Chem (2009) 0.79
Limited adherence to safety instructions in drug leaflets. Br J Clin Pharmacol (2002) 0.79
Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study. Cancer Med (2014) 0.79
Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US. Drug Healthc Patient Saf (2011) 0.78
Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson's disease: a retrospective claims database analysis. Appl Health Econ Health Policy (2013) 0.78
Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial. Am Heart J (2016) 0.78
Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation. Am J Nephrol (2015) 0.78
A limited number of prescribed drugs account for the great majority of drug-drug interactions. Eur J Clin Pharmacol (2014) 0.77
Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents. Antimicrob Agents Chemother (2014) 0.77
An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures. Patient Prefer Adherence (2012) 0.77
The association between antihypertensive drugs and glioma. Br J Cancer (2006) 0.77
Potentially inappropriate drug use among older persons in Finland: application of a new national categorization. Eur J Clin Pharmacol (2012) 0.77
National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection. Am J Transplant (2016) 0.76
Statins and subarachnoid hemorrhage in Medicare patients with unruptured cerebral aneurysms. Int J Stroke (2015) 0.76
Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study. Eur J Clin Pharmacol (2003) 0.76
Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use. Pharmacoepidemiol Drug Saf (2016) 0.76
Adherence to guidelines for avoiding drug interactions associated with warfarin--a Nationwide Swedish Register Study. PLoS One (2014) 0.76
Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study. Eur J Clin Pharmacol (2012) 0.75
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study. Diabetes Ther (2016) 0.75
Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults: an explorative case control study. PLoS One (2014) 0.75
Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data. Transplant Proc (2016) 0.75
Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use. Pediatr Blood Cancer (2016) 0.75
Dopaminergic and serotonergic drug use: a nationwide register-based study of over 1,300,000 older people. PLoS One (2011) 0.75
Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry. J Rheumatol (2016) 0.75
A systematic review of medication exposure assessment in prospective cohort studies of community dwelling older australians. PLoS One (2015) 0.75
The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care. Eur J Clin Pharmacol (2014) 0.75
Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life. Drugs Aging (2017) 0.75
Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis. J Am Heart Assoc (2017) 0.75
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet (1995) 5.02
The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol (2000) 3.43
Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther (2011) 3.36
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2001) 2.14
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers. Circulation (1992) 2.10
Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol (2004) 2.03
Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses. J Thromb Haemost (2013) 1.98
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit (2002) 1.60
A cytochrome b5 is required for full activity of flavonoid 3', 5'-hydroxylase, a cytochrome P450 involved in the formation of blue flower colors. Proc Natl Acad Sci U S A (1999) 1.54
Simpson's paradox: an example from hospital epidemiology. Epidemiology (2000) 1.51
Women with angina pectoris receive less antiplatelet treatment than men. Br J Gen Pract (1999) 1.51
Reproducibility of childhood respiratory symptom questions. Eur Respir J (1992) 1.49
Pharmacogenetics: from bench to byte. Clin Pharmacol Ther (2008) 1.40
Ruptured abdominal aortic aneurysms: factors influencing postoperative mortality and long-term survival. Eur J Vasc Endovasc Surg (1998) 1.39
Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records. Neth J Med (1999) 1.22
Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf (2001) 1.21
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res (1994) 1.18
Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia (2013) 1.18
Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol (2001) 1.17
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2010) 1.17
Long term persistence with statin treatment in daily medical practice. Heart (2004) 1.13
The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clin Exp Rheumatol (1993) 1.13
Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol (2002) 1.12
Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur J Immunol (2000) 1.12
Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke (2000) 1.10
Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol (2000) 1.10
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement. Clin Pharmacol Ther (2006) 1.08
Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. J Clin Pharm Ther (2004) 1.07
Postpneumonectomy pulmonary edema. A retrospective analysis of incidence and possible risk factors. Chest (1997) 1.06
Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol (1993) 1.05
Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci (1999) 1.05
Interpretation and inference in noninferiority randomized controlled trials in drug research. Clin Pharmacol Ther (2010) 1.02
An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system. Thromb Haemost (1986) 1.00
Undertreatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol (2003) 0.98
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. Br J Cancer (2010) 0.96
Is placebo analgesia mediated by endogenous opioids? A systematic review. Pain (1998) 0.93
Selection of oncology medicines in low- and middle-income countries. Ann Oncol (2014) 0.93
Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Hum Hypertens (2004) 0.89
Within-patient variability of myogenic motor-evoked potentials to multipulse transcranial electrical stimulation during two levels of partial neuromuscular blockade in aortic surgery. Anesth Analg (1999) 0.89
Undertreatment of hypertension in a population-based study in The Netherlands. J Hypertens (1998) 0.89
Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease. Resuscitation (2012) 0.88
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. Br J Clin Pharmacol (2002) 0.88
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease. Pharm World Sci (2001) 0.87
Risk of fracture in patients with Parkinson's disease. Osteoporos Int (2013) 0.87
Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens (1998) 0.87
Pathogenic potential and horizontal gene transfer in ovine gastrointestinal Escherichia coli. J Appl Microbiol (2009) 0.86
Determinants of DNA yield and purity collected with buccal cell samples. Eur J Epidemiol (2009) 0.86
The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Pituitary (2010) 0.86
Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J Hum Hypertens (2008) 0.86
Application of routine electronic health record databases for pharmacogenetic research. J Intern Med (2014) 0.85
Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Dermatol (1994) 0.85
Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. J Thromb Haemost (2011) 0.85
Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects. J Clin Epidemiol (2000) 0.84
Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis. Pharm World Sci (1996) 0.84
Influence of skinfold thickness on heparin absorption. Lancet (1991) 0.83
Carbon nanoparticles in lateral flow methods to detect genes encoding virulence factors of Shiga toxin-producing Escherichia coli. Anal Bioanal Chem (2010) 0.83
A rapid method to estimate the incidence rate and prevalence of insulin-dependent diabetes mellitus in children 0-19 years of age. Pharm World Sci (1995) 0.83
Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. J Clin Endocrinol Metab (2009) 0.82
Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol (2000) 0.82
Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis. Prev Vet Med (2013) 0.82
The association between antihypertensive drug therapies and plasma lipid levels in the general population. J Hum Hypertens (2001) 0.82
Fracture rate in patients with myasthenia gravis: the general practice research database. Osteoporos Int (2012) 0.82
Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. Pharmacoepidemiol Drug Saf (2007) 0.82
Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records. Pharmacoepidemiol Drug Saf (2002) 0.82
Risk of fracture in patients with muscular dystrophies. Osteoporos Int (2013) 0.82
Effect of nitrous oxide on myogenic motor potentials evoked by a six pulse train of transcranial electrical stimuli: a possible monitor for aortic surgery. Br J Anaesth (1999) 0.82
Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin. Neth J Med (2014) 0.81
Time-dependent propensity score and collider-stratification bias: an example of beta2-agonist use and the risk of coronary heart disease. Eur J Epidemiol (2013) 0.81
Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke. Pharmacogenomics J (2008) 0.80
Detection of drug interactions with single dose acenocoumarol: new screening method? Int J Clin Pharmacol Ther Toxicol (1990) 0.80
Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Pharmacogenomics J (2006) 0.80
Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Front Pharmacol (2013) 0.80
The Dutch vision of clinical pharmacology. Clin Pharmacol Ther (2009) 0.80
Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement. J Thromb Haemost (2013) 0.80
Validation of vibration testing for the assessment of the mechanical properties of human lumbar motion segments. J Biomech (2012) 0.79
Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis (1992) 0.79
Is drug treatment of hypertension in clinical practice as effective as in randomized controlled trials with regard to the reduction of the incidence of stroke? Epidemiology (2001) 0.79
The feasibility of modal testing for measurement of the dynamic characteristics of goat vertebral motion segments. J Biomech (2011) 0.79
Thoracic and thoracoabdominal aortic aneurysm repair: use of evoked potential monitoring in 118 patients. J Vasc Surg (2001) 0.79
Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis. Thromb Haemost (1985) 0.79
Cardio-pulmonary-bypass time has important independent influence on mortality and morbidity. Eur J Cardiothorac Surg (1997) 0.78
Disintegration of adhesion plaques in chicken embryo fibroblasts upon Rous sarcoma virus-induced transformation: different dissociation rates for talin and vinculin. Exp Cell Res (1990) 0.78
Quantitative falsification of instrumental variables assumption using balance measures. Epidemiology (2014) 0.78
Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis. Br J Clin Pharmacol (2007) 0.78
Reliability of dynamometry in patients with a neuromuscular disorder. Eng Med (1982) 0.78
The effect of two low-dose propofol infusions on the relationship between six-pulse transcranial electrical stimulation and the evoked lower extremity muscle response. Acta Anaesthesiol Scand (2000) 0.77
Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics J (2006) 0.77
The COAG and EU-PACT trials: what is the clinical benefit of pharmacogenetic-guided coumarin dosing during therapy initiation? Curr Mol Med (2014) 0.77
Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study. Pharm World Sci (2005) 0.76
Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs. Eur J Clin Pharmacol (2001) 0.76